SARAJEVO (Bosnia and Herzegovina), September 4 (SeeNews) – Bosnian pharmaceuticals maker Bosnalijek [SAJ:BSNLR] turned to a net profit of 4.55 million marka ($3.1 million/2.33 million euro) in the first half of 2014 from a net loss of 668,000 marka a year earlier, company data indicated.
Sales revenues rose 11.98% to 51.4 million marka through June, Bosnalijek said on its website.
(1 euro=1.95583 Bosnian marka)